A modified culture medium increases blastocyst formation and the efficiency of human embryonic stem cell derivation from poor-quality embryos
- PMID: 20657158
- DOI: 10.1262/jrd.09-225m
A modified culture medium increases blastocyst formation and the efficiency of human embryonic stem cell derivation from poor-quality embryos
Abstract
Human embryonic stem cells (HESCs) are defined as self-renewing cells that retain their ability to differentiate into all cell types of the body. They have enormous potential in medical applications and as a model for early human development. There is a need for derivation of new HESC lines to meet emerging requirements for their use in cell replacement therapies, disease modeling, and basic research. Here, we describe a modified culture medium containing human recombinant leukemia inhibitory factor and human basic fibroblast growth factor that significantly increases the number of human blastocysts formed and their quality, as well as the efficiency of HESC derivation from poor-quality embryos. Culturing poor-quality embryos in modified medium resulted in a two-fold increase in the blastocyst formation rate and a seven-fold increase over the derivation efficiency in conventional medium. We derived 15 HESC lines from poor-quality embryos cultured in modified culture medium and two HESC lines from quality embryos cultured in conventional culture medium. All cell lines shared typical human pluripotent stem cell features including similar morphology, normal karyotypes, expression of alkaline phosphatase, pluripotency genes, such as Oct4, and cell surface markers (SSEA-4, TRA-1-60, TRA-1-81), the ability to form teratomas in SCID mice, and the ability to differentiate into cells of three embryonic germ layers in vitro. Our data suggest that poor-quality embryos that have reached the blastocyst stage in our modified culture medium are a robust source for normal HESC line derivation.
Similar articles
-
Enhanced generation of human embryonic stem cells from single blastomeres of fair and poor-quality cleavage embryos via inhibition of glycogen synthase kinase β and Rho-associated kinase signaling.Hum Reprod. 2013 Oct;28(10):2661-71. doi: 10.1093/humrep/det309. Epub 2013 Aug 6. Hum Reprod. 2013. PMID: 23925393
-
Comparison of three embryo culture methods for derivation of human embryonic stem cells from discarded embryos.Cell Reprogram. 2011 Jun;13(3):233-9. doi: 10.1089/cell.2010.0092. Epub 2011 Mar 31. Cell Reprogram. 2011. PMID: 21453052
-
Whole-blastocyst culture followed by laser drilling technology enhances the efficiency of inner cell mass isolation and embryonic stem cell derivation from good- and poor-quality mouse embryos: new insights for derivation of human embryonic stem cell lines.Stem Cells Dev. 2008 Apr;17(2):255-67. doi: 10.1089/scd.2007.0157. Stem Cells Dev. 2008. PMID: 18447641
-
Use of insulin to increase epiblast cell number: towards a new approach for improving ESC isolation from human embryos.Biomed Res Int. 2013;2013:150901. doi: 10.1155/2013/150901. Epub 2013 Feb 12. Biomed Res Int. 2013. PMID: 23509681 Free PMC article. Review.
-
Derivation of human embryonic stem cell lines.Theriogenology. 2007 Jan 1;67(1):32-42. doi: 10.1016/j.theriogenology.2006.09.031. Epub 2006 Oct 30. Theriogenology. 2007. PMID: 17074383 Review.
Cited by
-
High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivation.Cell Biosci. 2014 Dec 2;4(1):74. doi: 10.1186/2045-3701-4-74. eCollection 2014. Cell Biosci. 2014. PMID: 25506417 Free PMC article.
-
Triploid and diploid embryonic stem cell lines derived from tripronuclear human zygotes.J Assist Reprod Genet. 2012 Aug;29(8):713-21. doi: 10.1007/s10815-012-9764-4. Epub 2012 Apr 12. J Assist Reprod Genet. 2012. PMID: 22527897 Free PMC article.
-
Selection and vitrification of embryos with a poor morphological score: a proposal to avoid embryo wastage.J Huazhong Univ Sci Technolog Med Sci. 2012 Jun;32(3):405-409. doi: 10.1007/s11596-012-0070-2. Epub 2012 Jun 9. J Huazhong Univ Sci Technolog Med Sci. 2012. PMID: 22684566 Clinical Trial.
-
Modeling neurodevelopmental disorders using human pluripotent stem cells.Stem Cell Rev Rep. 2014 Aug;10(4):494-511. doi: 10.1007/s12015-014-9507-2. Stem Cell Rev Rep. 2014. PMID: 24728983 Review.
-
The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.Sci Rep. 2016 Sep 1;6:32463. doi: 10.1038/srep32463. Sci Rep. 2016. PMID: 27581487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous